Book a demo
Skip to content

Stonewake Monitoring

Glucotrack, Inc. files 8-K covering a debt obligation

The Nasdaq-listed medical instruments company filed an 8-K on 2026-09-11 disclosing a debt arrangement, its second such filing within three days.

Export financeUSAPublished · 3 sourced facts

Glucotrack, Inc., a Delaware-incorporated surgical and medical instruments maker trading on Nasdaq under the ticker GCTK, filed an 8-K on September 11, 2026.[1][2]

The filing, under accession number 0001493152-26-042428, covers a debt obligation and includes Items 1.01, 2.03, 3.02, 7.01, and 9.01, with a period ending 2026-09-10.[1]

This follows an earlier 8-K filed on 2026-09-09, under accession number 0001493152-26-041978, which also reported a debt obligation.[3]

Sources

  1. [1]SEC EDGAR: 8-K, 0001493152-26-042428, 11 Sep 2026
  2. [2]SEC EDGAR: CIK 0001506983, Glucotrack, Inc.
  3. [3]SEC EDGAR: 8-K, 0001493152-26-041978, 9 Sep 2026

SEC EDGAR

← All briefs